Skip to main content
. 2022 Aug 19;3(8):e222663. doi: 10.1001/jamahealthforum.2022.2663

Figure 3. Share of Naloxone Claims by Drug Brand Among Insured and Uninsured Populations, 2010-2018.

Figure 3.

The graphs include the share percentages for Evzio, generic naloxone, and Narcan, corresponding to each year in which the drugs were available among the insured population (A) and uninsured population (B).